资讯 | 阿里巴巴(BABA)财报超预期,股价收高3%

wechat omage

美股

北京时间8月16日凌晨,美股周四收盘涨跌不一。道指上涨约100点,道指成份股、零售业巨头沃尔玛领涨。投资者仍在关注国际贸易关系进展、企业财报及美国国债市场动态。昨日美债收益率倒挂导致美股重挫。

截止收盘,道指涨99.97点,或0.39%,报25579.39点;标普500指数涨7.00点,或0.25%,报2847.60点;纳指跌7.32点,或0.09%,报7766.62点。

周四道指收高100点,沃尔玛(WMT)收高6.1%,成为涨幅最大的道指成份股。

通用电气(GE)收跌11.3%,创2008年4月以来的最大单日跌幅。此前,麦道夫的举报者Harry Markopolos称通用电气涉嫌财务报表作假以隐瞒严重财务问题,并将其称为“比安然公司更大的欺诈行为”。

昨日美国国债市场发出了经济衰退正在迫近的强烈预警讯号,使当天美股遭遇重创,道指暴跌800点,录得历史上第四大单日跌幅,并降至两个月来的最低水平。

本周迄今美股宽幅震荡,标普500指数周一收跌1.2%,周二反弹1.5%,但在周三猛烈下跌2.9%,连续三日涨跌幅都超过1%。

周四美国2年期与10年期国债收益率仍处在随时可能发生倒挂的边缘,而30年期国债收益率首次跌破2%,创历史新低。

市场仍在关注美联储的政策前景。圣路易斯联储行长詹姆斯-布拉德(James Bullard)周四表示:“我们关注市场与数据。这是一场全球性的经济放缓,我们必须评估它会如何影响美国。”

布拉德称美国消费状况良好,但贸易摩擦构成许多不确定性。美联储出于安全考虑而下调利率。布拉德表示,美联储想要达到通胀目标,并且不介意通胀率高于2%。

关于近期美股市场波动,布拉德认为,美国劳动力市场表现良好,增速合理,考虑到美国的数据,近期的一些市场跌势可能“过头”了。

在谈及国债收益率倒挂时,布拉德指出,近期美国国债收益率大幅下跌的部分原因是“资金涌入安全资产”,国债收益率倒挂现象必须是持续存在的,才是经济衰退的讯号。

焦点个股:

阿里巴巴(BABA)收高3%。该公司报告称,2020财年第一季度总营收为1149.2亿元人民币,市场预期为1117.34亿元,去年同期为809.2亿元。第一季度调整后每股收益12.55元,市场预估10.28元。

沃尔玛2020财年第二季度总营收为1304亿美元,市场预期为1301.06亿美元,去年同期为1280.3亿美元。第二季度净销售额为1293.9亿美元,去年同期为1270.6亿美元。

亚马逊(AMZN)股价攀升,此前伯克希尔哈撒韦(298066.9, 3066.90, 1.04%)宣布第二季度对亚马逊的持股增加11%。

唯品会大涨15%。该公司第二季度财报好于预期。唯品会披露了其未经审计的2019年第二季度财务报告显示,二季度净营收增至227亿人民币(约合33亿美元),同比增长9.7%。归属股东净利润为11亿元人民币(约合1.548亿美元),同比增长84.2%。

周四思科(CSCO)收盘重挫8.6%,此前该公司预测未来盈利将低于预期,因为将受到国际贸易紧张关系的“严重影响”。此外,思科向加州监管部门提交的文件显示,该公司已裁减了硅谷的近500个工作职位。投行杰富瑞将思科目标价从62美元下调至54美元。

瑞幸收高1.2%。该公司周三公布了上市后的首份成绩单,第二季度净亏损6.11亿元,同比扩大83.4%。昨日该股重挫16.7%。
 

   

港股

北京时间8月15日,美股周三大幅收跌。道指暴跌逾800点。疲软的亚欧经济数据令人担忧全球经济放缓。一项重要的美债收益率出现倒挂,拉响了美国经济衰退的强烈预警讯号。今日开盘,港股恒指低开1.41%,失守25000点,之后强势反弹。

截至收盘,恒生指数涨0.76%,报25495.46点;国企指数涨0.38%,报9903.41点;红筹指数涨0.93%,报4024.34点

沪港通资金流向方面,沪股通净流出6.98亿,港股通(沪)净流入37.08亿。

深港通资金流向方面,深股通净流入8.36亿,港股通(深)净流入9.1亿。

热点板块:

香港本地股集体走强,新世界发展涨7.81%,九龙仓置业4.69%,港铁公司涨4.42%。对于香港特区行政长官林郑月娥日前亲自召开的商界会议,香港行政长官办公室回应称,该会议就现时香港的情况与商界交流,研究特区政府和全港各界应该怎样共同努力,走出这个经济困境。行政长官亦请财政司司长领导相关同事制订一系列纾解民困和协助企业的措施,支持香港的经济和协助有需要的香港市民。特区政府在适当时候会做出公布。

受联通业绩大好提振,三大运营商集体大涨,中国联通(8, 0.18, 2.30%)大涨10.92%,中国电信(3.57, -0.03, -0.83%)大涨5.88%,中国移动(66.95, 0.85, 1.29%)大涨5.42%。另外,5G到来的步伐,比想象中的要快。针对此前业界传出的“三大运营商将自今年国庆起展开5G商用”消息,中国电信北京公司近日介绍,中国电信已决定今年9月率先在京放出5G专用号段的手机号码。

腾讯控股跌2.82%,报330.4元。腾讯昨日日公布2019年二季度业绩,第二季度收入888.2亿元,市场预期934.24亿元,同比增21%,主要是受商业支付服务及其他金融科技服务、智能手机游戏及其他数字内容销售所推动。第二季度净利润241.4亿元人民币,同比增35%,同比增速创2018年二季度以来新高,市场预估211亿元人民币。

 

中国A股

北京时间8月15日,三大股指早盘全线低开,随后开始回暖,创指一度翻红。临近上午收盘,指数回落,创指跌绿,盘面上看,公交、钢铁板块拉升,医药、中船系概念持续强势。午后,三大股指持续回暖,三大股指全线翻红,创业板指涨幅扩大至1%。盘面上,影视股异动,国产软件概念股走强。临近盘尾,指数企稳震荡,券商板块拉升,工业大麻概念走强。总体上,个股涨跌比逐渐收窄,两市情绪明显回暖,不过成交量仍处低位。

截止收盘,沪指报2815.80点,涨0.25%;深成指报9009.68点,涨0.48%。

从盘面上看,医药、华为海思、消费电子、工业大麻概念股居涨幅榜前列,草甘膦、种植业、石油开采板块居跌幅榜前列。

热点板块:

医药板块领涨,易明医药、健民集团、西藏药业、众生药业、兴齐眼药等多股涨停,哈药股份、康恩贝、仁和药业等均有走强。

消息面上部分药品全国性降价通道开启。据悉,有关部门日前已就全国范围内推开“4+7”带量采购试点进行相关部署,要求未实行地区上报公立医疗机构相关药品2017年、2018年实际采购数据。据权威人士透露,我国已确定全面跟进“带量采购”。此次采购价格不得高于此前“4+7”带量采购试点中标价。若针对同个药品多个药企报价,报价最低企业直接中标,其余企业依次决定是否接受最低报价跟进,直至中选企业满3家。

华为概念持续走强,易尚展示涨停,录得4连板。此外,苏大维格、美格智能、维科技术、江海股份等个股均涨停。
 
如果有想了解更多全球股市资讯,请关注微信公众共 “辉立资本新加坡” (SGPSPL)

同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股,中国A股,越南股票,韩国股票,德国股票,马来西亚股票,泰国股票,印尼股票,菲律宾股票,日本股票,澳大利亚股票,台湾股票,加拿大股票,英国股票,法国股票,荷兰股票,葡萄牙股票,比利时股票,土耳其股票
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com